ARTA
ARCT icon

A.R.T. Advisors’s Arcturus Therapeutics ARCT Stock Holding History

A.R.T. Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,171
Closed -$128K – 1477
2017
Q4 		$128K Buy
16,171
+13,174
+440% +$118K 0.01% 1230
2017
Q3 		$21K Sell
2,997
-2,375
-44% -$17.9K ﹤0.01% 1290
2017
Q2 		$42K Sell
5,372
-20,013
-79% -$161K ﹤0.01% 1317
2017
Q1 		$202K Buy
+25,385
New +$235K 0.01% 1167
2016
Q3 		– Sell
-3,363
Closed -$105K – 658
2016
Q2 		$105K Sell
3,363
-704
-17% -$22.2K 0.01% 1198
2016
Q1 		$107K Sell
4,067
-2,471
-38% -$83.7K ﹤0.01% 1249
2015
Q4 		$287K Sell
6,538
-5,115
-44% -$230K 0.01% 1075
2015
Q3 		$492K Buy
+11,653
New +$613K 0.02% 880
2015
Q1 		– Sell
-14,767
Closed -$385K – 1413
2014
Q4 		$385K Buy
+14,767
New +$470K 0.01% 1011

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

A.R.T. Advisors's ARCT Position: Q1 2018 in Review

A.R.T. Advisors sold out of Arcturus Therapeutics (ARCT) in Q1 2018, closing a stake of 16,171 shares — an estimated $128K sold.

A.R.T. Advisors first reported a position in ARCT in Q4 2014 and held it in 9 quarters. The position peaked at $492K in Q3 2015. 18 funds tracked by Wall St. Rank hold ARCT as of Q1 2018.

  • A.R.T. Advisors reported no remaining Arcturus Therapeutics position as of Q1 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 16,171 Arcturus Therapeutics shares in Q1 2018, an estimated $128K.
  • A.R.T. Advisors first reported a position in Arcturus Therapeutics in Q4 2014 and held it in 9 quarters.
  • A.R.T. Advisors's Arcturus Therapeutics position peaked at $492K in Q3 2015.
  • 18 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2018.

Based on A.R.T. Advisors's 13F filing for Q1 2018, filed 15 May 2018.